AACR 2026 海报库

LBPO.CL01 Late-Breaking Research: Clinical Research 1 PO.CL01.01 Biomarkers Predictive of Therapeutic Benefit 1 PO.CL01.02 Biomarkers Predictive of Therapeutic Benefit 2 PO.CL01.07 Liquid Biopsies: Circulating Nucleic Acids 1 PO.CL01.12 Spatial Proteomics and Transcriptomics 1 PO.CL01.15 Prognostic Biomarkers 1 PO.CL01.18 Early Detection Biomarkers 1 PO.CL01.22 Circulating Tumor Cells, Metastasis, and Dissem… PO.CL06.02 Mechanistic Insights for Targeted Therapies in … PO.CL07.03 Targeting DNA Repair, Cell Cycle, and Tumor Met… PO.CL11.02 Survivorship, Supportive Care, and Quality of L… LBPO.CL02 Late-Breaking Research: Clinical Research 2 PO.CL01.03 Biomarkers Predictive of Therapeutic Benefit 3 PO.CL01.08 Liquid Biopsies: Circulating Nucleic Acids 2 PO.CL01.19 Early Detection Biomarkers 2 PO.CL04.01 Cancer and Aging: Implications for Outcomes PO.CL04.02 Community-Engaged Approaches to Equity Across t… PO.CL05.05 Immunomodulatory Effects of Targeted Therapies PO.CL05.11 Redefining Targeted Therapy: Bispecific T-Cell … PO.CL07.01 Data-Driven Approaches to Precision Oncology PO.CL07.05 Targeted Antigen Therapies and Immunity PO.CL12.04 Molecular Imaging, Radiomics, and Theranostics PO.CL01.04 Biomarkers Predictive of Therapeutic Benefit 4 PO.CL01.09 Liquid Biopsies: Circulating Nucleic Acids 3 PO.CL01.13 Spatial Proteomics and Transcriptomics 2 PO.CL01.16 Prognostic Biomarkers 2 PO.CL01.20 Diagnostic Biomarkers 1 PO.CL01.23 Circulating Tumor Cells, Metastasis, and Dissem… PO.CL05.01 Adoptive Cell Therapy 1 PO.CL05.03 Combination Immunotherapies PO.CL07.02 Molecular Targeted Therapy PO.CL12.01 Molecular Classification and Tumor Biology in C… PO.CL01.05 Biomarkers Predictive of Therapeutic Benefit 5 PO.CL01.10 Liquid Biopsies: Circulating Nucleic Acids 4 PO.CL01.17 Prognostic Biomarkers 3 PO.CL05.02 Adoptive Cell Therapy 2 PO.CL05.12 Redefining Targeted Therapy: Bispecific T-Cell … PO.CL08.02 Effects of Ionizing Radiation on Normal Tissues… PO.CL09.01 Precision Oncology and Real World Data PO.CL09.03 Retrospective Observational Studies PO.CL11.01 Biological and Clinical Consequences of Cancer … PO.CL12.03 Epigenetics, Cytogenetics, and Clinical Molecul… LBPO.CL03 Late-Breaking Research: Clinical Research 3 PO.CL01.14 Spatial Proteomics and Transcriptomics 3 PO.CL01.21 Diagnostic Biomarkers 2 PO.CL02.01 Biostatistics in Clinical Trials / Surgical Onc… PO.CL05.04 Immune Checkpoint Blockade PO.CL05.06 Clinical Correlates of Immunotherapy PO.CL05.09 Inflammation, Immunity, and Cancer PO.CL05.13 Vaccines and Other Immunomodulatory Agents PO.CL07.04 Combination Targeted Therapy PO.CL08.01 Radiation and Photodynamic Therapy Response Mod… PO.CL09.02 Real World Data to Provide Real World Evidence LBPO.CL04 Late-Breaking Research: Clinical Research 4 PO.CL01.06 Biomarkers Predictive of Therapeutic Benefit 6 PO.CL01.11 Liquid Biopsies: Circulating Nucleic Acids 5 PO.CL05.07 Immune Response to Therapies PO.CL05.08 Immunomodulatory Agents and Interventions PO.CL05.10 Tumor Microenvironment Modulators PO.CL06.01 Immunotherapies in Pediatric Cancers PO.CL06.03 Targeted Therapies, Predispositions, and Surviv… PO.CL09.04 Real World Impact of Prognostic and Predictive … PO.CL12.02 Translational Biomarkers and Emerging Molecular…

LBPO.ET01 Late-Breaking Research: Experimental and Molecu… PO.ET01.02 Mechanism-Guided Development of Targeted Cancer… PO.ET01.04 Kinase and Signaling Pathway Dependencies Drivi… PO.ET02.07 Innovative Therapeutic Modalities and Translati… PO.ET02.09 RNA, Gene and Cell Therapies, and Enabling Assa… PO.ET02.11 Novel Therapeutics and Drug Targets 1 PO.ET03.01 Mechanisms of Drug Resistance 1 PO.ET04.01 Gene and Vector-Based Therapy PO.ET06.02 DNA Damage and Repair 1 PO.ET09.06 Novel Antitumor Agents 1 PO.ET01.01 Engineering the Next Wave of Antibody-Based Can… PO.ET02.01 Antibody-Drug Conjugates and Linker Engineering… PO.ET02.02 Antibody-Drug Conjugates and Linker Engineering… PO.ET02.05 Antibody Technologies and Platforms 1 PO.ET03.02 Mechanisms of Drug Resistance 2 PO.ET03.07 Targeting Drug Resistance 1: Apoptosis and Auto… PO.ET03.08 Targeting Drug Resistance 2: RAS Signaling PO.ET06.03 DNA Damage and Repair 2 PO.ET07.01 Quantitative Pharmacology and Translational Mod… LBPO.ET02 Late-Breaking Research: Experimental and Molecu… PO.ET01.06 Targeting Cell Surface Vulnerabilities to Overc… PO.ET02.08 Nanocarriers and Drug Delivery Systems PO.ET02.12 Novel Therapeutics and Drug Targets 2 PO.ET03.04 Overcoming Chemotherapy Resistance PO.ET03.06 Drug Resistance 1: Antibodies and ADCs PO.ET05.02 Cellular Responses to Anticancer Drugs PO.ET06.04 Molecular Targets 1 PO.ET07.02 Pharmacogenomics and Translational Biomarkers f… PO.ET09.09 Novel Targets and Pathways PO.ET01.03 Next-Generation Targeted Therapies Directed Aga… PO.ET02.03 Antibody-Drug Conjugates and Linker Engineering… PO.ET02.06 Antibody Technologies and Platforms 2 PO.ET02.10 Drug Combinations, Repurposing, and Differentia… PO.ET02.13 Hematologic Malignancies and Novel Therapeutic … PO.ET08.01 Strategies to Enhance the Therapeutic Index of … PO.ET09.01 Epigenetic Modulators 1 PO.ET09.03 Proximity-Induced Drug Discovery 1 PO.ET09.07 Novel Antitumor Agents 2 LBPO.ET03 Late-Breaking Research: Experimental and Molecu… PO.ET02.04 Antibody-Drug Conjugates and Linker Engineering… PO.ET02.14 Tumor Microenvironment, Multispecifics, and Imm… PO.ET05.01 Mechanisms of Anticancer Drug Action PO.ET06.01 Cell Death Pathways and Treatment PO.ET06.05 Molecular Targets 2 PO.ET08.02 Radiopharmacuetical Platforms for Theranostic P… PO.ET09.04 Proximity-Induced Drug Discovery 2 PO.ET09.05 Multi-Axis Antineoplastic Agents PO.ET09.10 Tyrosine Kinase, Phosphatase, and Other Inhibit… LBPO.ET04 Late-Breaking Research: Experimental and Molecu… PO.ET01.05 Overcoming Microenvironmental and Delivery Barr… PO.ET03.03 Novel Strategies to Reverse Drug Resistance PO.ET03.05 Drug Resistance 2: Tyrosine Kinase Inhibitors PO.ET05.03 Role of the Microenvironment in Therapeutic Res… PO.ET06.06 Tumor Diagnostics, Prognostics, and Therapeutic… PO.ET08.03 Targeted Radiopharmaceuticals and Combination S… PO.ET09.02 Epigenetic Modulators 2 PO.ET09.08 Novel Antitumor Agents 3

PO.TB02.02 Molecular Pathology PO.TB04.01 Ex Vivo Systems: Patient-Derived, Patient-Speci… PO.TB04.05 Noninvasive Imaging and Analysis of Animal and … PO.TB05.01 Developmental Origins, Drivers, and Heterogenei… PO.TB07.01 Stem Cell Plasticity and Lineage Reprogramming … PO.TB09.03 Methods to Measure Tumor Evolution and Heteroge… PO.TB10.06 Spatial Protein Profiling and Multi-Modal Mappi… PO.TB10.12 Physicochemical Modulation of Cancer Ecosystems… PO.TB02.01 In Vivo Imaging PO.TB03.01 Therapies Targeting Metastasis PO.TB03.04 Characterization of Metastases by Imaging and P… PO.TB04.06 In Vivo Models 1: Mouse, Zebrafish, and Alterna… PO.TB07.02 Metabolic and Transcriptional Control of Cancer… PO.TB10.01 Tumorigenesis and Early Microenvironmental Traj… PO.TB10.05 Aging and Host Determinants of Tumor Progressio… PO.TB10.10 Tertiary Lymphoid Structures in Cancer LBPO.TB01 Late-Breaking Research: Tumor Biology 1 PO.TB03.05 Migration and Invasion PO.TB04.02 Humanized Mouse Models PO.TB04.07 In Vitro Models 1: 2D and 3D PO.TB05.03 Pediatric Cancer Genomics and Epigenomics PO.TB09.02 Tumor Evolution PO.TB10.03 Microenvironmental Determinants of Therapy Resp… PO.TB10.15 Extracellular Vesicles and Long-Range Tumor-Hos… PO.TB10.17 Therapeutic Modulation of the Tumor Microenviro… LBPO.TB02 Late-Breaking Research: Tumor Biology 2 PO.TB01.01 Angiogenesis PO.TB03.02 Epithelial-to-Mesenchymal Transition PO.TB04.03 In Vitro Models 2: 2D, 3D, Organoids, and Spher… PO.TB07.03 Contextual Determinants of Cancer Stemness and … PO.TB10.08 Spatial Niches and Functional Boundaries within… PO.TB10.14 Microbiome-Tumor-Immune Crosstalk PO.TB10.18 Novel Experimental Platforms and Causal Inferen… PO.TB10.19 Tumor-Immune Crosstalk PO.TB03.03 Mechanisms of Metastasis PO.TB03.06 Metastatic Niches and Microenvironment PO.TB04.04 In Vivo Models 2: Genetically Engineered Mouse … PO.TB05.02 Pediatric Cancer Models PO.TB10.02 Metastasis and Organ-Specific Microenvironmenta… PO.TB10.07 Spatial Niches and Functional Boundaries within… PO.TB10.11 Fibroblasts as Architects of the Tumor Microenv… PO.TB10.13 Tumor-Neuron Interactions and Neuro-Regulation … LBPO.TB03 Late-Breaking Research: Tumor Biology 3 PO.TB04.08 Tumor Models and Assays: In Vitro, In Vivo PO.TB06.01 Biological Mechanisms of Tumor and Normal Tissu… PO.TB08.01 Tumor Adhesion PO.TB09.01 Tumor Heterogeneity PO.TB10.04 Microenvironmental Determinants of Therapy Resp… PO.TB10.09 Functional and Spatial Regulation of Immune Eva… PO.TB10.16 Therapeutic Modulation of the Tumor Microenviro…

LBPO.MCB01 Late-Breaking Research: Molecular/Cellular Biol… PO.MCB02.02 Targeting Mitochondria and Metabolic Vulnerabil… PO.MCB03.03 Tumor Cell Plasticity, Microenvironment, and St… PO.MCB05.02 Mechanisms and Targets in DNA Damage Repair PO.MCB08.01 Genomic Dissection to Define Novel Therapeutic … PO.MCB09.03 Metabolite Control of Chromatin, Redox, and Cel… PO.MCB11.01 Tumor Suppressors PO.MCB01.01 Cell Cycle PO.MCB06.01 Chromatin Structure and Function PO.MCB06.02 DNA Methylation PO.MCB08.02 Genomic Drivers of Cancer Pathogenesis PO.MCB09.01 Metabolic Regulation in Breast and Gynecologic … PO.MCB10.01 MicroRNAs as Cancer Biomarkers, Therapeutic Tar… PO.MCB03.02 RTK-ERBB-PI3K and New Targets in Therapeutic Re… PO.MCB06.03 Epigenetic Changes as Molecular Markers of Canc… PO.MCB06.04 Epigenomics PO.MCB08.03 Genomic Profiling to Understand Cancer Biology PO.MCB09.04 Metabolic Studies in Brain, Pediatric, and Hema… PO.MCB11.02 Tumorigenesis Drivers LBPO.MCB02 Late-Breaking Research: Molecular/Cellular Biol… PO.MCB02.01 Cell Death Regulation and Therapeutic Resistanc… PO.MCB05.01 Insights into Genomic Instability PO.MCB07.01 Oncogenic Transcription Factors and Cancer Prog… PO.MCB09.05 Metabolic Features of Thoracic and Urologic Can… PO.MCB09.06 Metabolic Alterations in Colorectal and Gastroi… PO.MCB03.01 RAS/MAPK Signaling, KRAS Targeting, and Adaptiv… PO.MCB04.02 Senescence and Cell Stress PO.MCB07.03 Mechanisms and Dynamics of Gene Expression PO.MCB08.04 Genetic and Transcriptomic Dissection of Cancer… PO.MCB10.02 Functional Roles of Noncoding RNAs in Cancer Pr… PO.MCB04.01 Hypoxic and Proteotoxic Stress Response PO.MCB07.02 Chromatin Architecture and Regulatory Landscapes PO.MCB07.04 Transcription Factor Function in Cell Identity,… PO.MCB08.05 Genomic Approaches to Define Tumor Biology and … PO.MCB09.02 Metabolic Vulnerabilities in Pancreatic, Hepati…

LBPO.IM01 Late-Breaking Research: Immunology 1 PO.IM01.01 Immune Cell Biology and Tumor-Immune Crosstalk PO.IM01.07 Alternative Cell Type and in Situ Cell Therapies PO.IM02.01 Inflammation and Cancer Progression PO.IM03.01 Virology and Cancer LBPO.IM02 Late-Breaking Research: Immunology 2 PO.IM01.05 CAR T Cell Targets and TME Reprogramming PO.IM01.10 Combination Immunotherapies PO.IM01.16 T Cell Engagers 1 PO.IM02.02 Innate Immunity in Cancer PO.IM01.02 Modifiers of Inflammation and the Tumor Microen… PO.IM01.04 Immune Mechanisms Invoked by Other Therapies an… PO.IM01.11 Immune Checkpoints PO.IM02.03 Microbiome, Inflammation, and Response to Immun… LBPO.IM03 Late-Breaking Research: Immunology 3 PO.IM01.03 Vaccine Platforms and Target Identification PO.IM01.06 CAR T Cell Functional Enhancement PO.IM01.12 Immunomodulatory Agents PO.IM01.15 Monoclonal Antibodies and Antibody-Cytokine Pla… PO.IM02.04 Adaptive Immunity in Cancer PO.IM01.08 TCR and Autologous T Cell Therapies PO.IM01.09 T Cell Engagers 2 / Antibody-Drug Conjugates 1 PO.IM01.14 Bi- and Tri-Specific Antibody Therapies PO.IM02.06 Oncogenic Pathways and Cancer Immunity PO.IM01.13 Antibody-Drug Conjugates 2 PO.IM01.17 High-Dimensional Immune Profiling and Preclinic… PO.IM02.05 Tumor-induced Immune Suppression PO.IM02.07 Novel Models of Immunotherapy Response

PO.BCS01.01 Application of Bioinformatics to Cancer Biology… PO.BCS01.06 Digital Pathology 1 PO.BCS01.11 Liquid Biopsy: Multi-Analyte and Multi-Omic PO.BCS02.01 Agentic AI in Cancer LBPO.BCS01 Late-Breaking Research: Bioinformatics, Computa… PO.BCS01.02 Application of Bioinformatics to Cancer Biology… PO.BCS01.07 Digital Pathology 2 PO.BCS01.09 Integrative Computational Approaches 1 PO.BCS01.15 Sequence Analysis PO.BCS01.03 Application of Bioinformatics to Cancer Biology… PO.BCS01.16 Integration of Clinical and Research Data PO.BCS02.02 Large Language Models in the Clinic PO.BCS02.04 Radiomics and AI in Medical Imaging PO.BCS01.04 Application of Bioinformatics to Cancer Biology… PO.BCS01.08 Digital Pathology 3 PO.BCS01.10 Integrative Computational Approaches 2 PO.BCS02.06 Machine Learning Approaches for Cancer Predicti… PO.BCS01.05 Application of Bioinformatics to Cancer Biology… PO.BCS01.12 New Software Tools for Data Analysis PO.BCS02.03 Machine Learning for Image Analysis PO.BCS02.05 Deep Learning in Cancer LBPO.BCS02 Late-Breaking Research: Bioinformatics, Computa… PO.BCS01.13 New Algorithms and Computational Methods PO.BCS01.14 Network Biology and Precision Medicine PO.BCS01.17 Mathematical Modeling and Statistical Methods

PO.PS01.04 Survivorship Research Addressing Cancer Dispari… PO.PS01.10 Survivorship Research PO.PS01.01 Biomarkers of Endogenous or Exogenous Exposures… PO.PS01.05 Epidemiology: Cancer Incidence, Mortality, Patt… PO.PS01.02 Cancer Surveillance: Emerging Cancer Trends and… PO.PS01.07 Genetic Epidemiology 1: GxE, GWAS, Polygenic Ri… PO.PS01.03 Etiology and Molecular Epidemiology Approaches … PO.PS01.06 Diet, Alcohol, and Tobacco, and Other Lifestyle… LBPO.PS01 Late-Breaking Research: Population Sciences PO.PS01.08 Genetic Epidemiology 2: Pathway Analysis, Seque… PO.PS01.12 Environmental and Occupational Risk Factors, In… PO.PS01.09 Risk Prediction Modeling, Screening, Early Dete… PO.PS01.11 Psychosocial and Behavioral Epidemiology, Healt…

LBPO.CH01 Late-Breaking Research: Chemistry PO.CH01.07 Computational, Technological, and Mechanistic A… PO.CH01.06 Antibodies, Antibody-Drug Conjugates, and Nucle… PO.CH03.01 Structural and Chemical Biology PO.CH01.05 Natural Products PO.CH01.01 Targeted Protein Degradation and Induced Proxim… PO.CH01.03 New Ligands and Inhibitors PO.CH01.02 Screening and Technology Advances for Probe and… PO.CH01.04 Drug Delivery PO.CH02.01 Proteomics: Biomarker Discovery and Signaling N… PO.CH02.02 Multi-Omics, Systems Biology, and Biological Ma…

PO.PR02.01 Experimental Chemoprevention and Interception: … PO.PR02.03 Cancer in the Community: Epidemiology, Experime… PO.PR01.01 Cancer Disparities LBPO.PR01 Late-Breaking Research: Prevention, Early Detec… PO.PR01.04 Metabolism and Microbiome in Cancer Initiation … PO.PR01.02 Early Detection and Interception PO.PR01.03 Genomics, Proteomics, Biomarkers, and Risk Stra… PO.PR01.05 Advances in Survivorship PO.PR02.02 Cancer and Cancer Related Alterations, Detectio…

PO.CT01.02 First-in-Human Phase I Clinical Trials PO.CT01.01 Phase 0 and First-in-Human Phase I Clinical Tri… PO.CT01.05 Phase II and Phase III Clinical Trials PO.CT01.03 Phase I Clinical Trials PO.CT01.04 Phase II Clinical Trials

PO.CTP01.01 Phase I Clinical Trials in Progress PO.CTP01.03 Phase II and Phase III Clinical Trials in Progr… PO.CTP01.02 Phase I and Phase II Clinical Trials in Progress

PO.SHP01.01 Science and Health Policy 1 PO.SHP01.02 Science and Health Policy 2

PO.ADV01 Advocates Poster Session 1 PO.ADV02 Advocates Poster Session 2

PO.EN01.01 Hormone Receptor Signaling and Therapeutic Targ… PO.EN01.02 Signaling Pathways, Metabolism, and Emerging Th…

PO.MD01.01 AACR Project GENIE: Predictive Models and AI PO.MD01.02 AACR Project GENIE: Genomic Characterization

PO.RSP01.01 Regulatory Science and Policy

PO.SCIED01 2026 AACR Undergraduate Scholars and Margaret F…